• Clinical Outcome Study

    Clinical Outcome Study

    An opportunity to participate in a clinical research study that is essential for defining outcome measures for clinical trials by measuring how these conditions develop and progress. Without good clinical outcomes, effective clinical trials cannot be performed.
    Read more

  • Importance of Genetic Diagnosis

    Importance of Genetic Diagnosis

    Since multiple forms of muscular dystrophy can have similar clinical symptoms, genetic analysis is the only definitive way to confirm your diagnosis of LGMD2B / Miyoshi. The Jain Foundation can help you obtain this genetic analysis.
    Read more

  • About the Disease

    About the Disease

    LGMD2B/Miyoshi Myopathy (collectively called dysferlinopathy) are rare forms of muscular dystrophy caused by mutations in the dysferlin gene. For the disease to occur both copies of the dysferlin gene must be defective (recessive inheritance).
    Read more

Patient StoryPatient Story

Patient Story

Bliss

On February 26, 1981, I was born a healthy baby girl. I had what most would call a normal childhood. I was very active and played soccer and swam for my neighborhood swim team. However, about six months after my sixteenth birthday, I noticed I was having difficulty climbing stairs.
Read more...

News and Update

The Jain Foundation is happy to share a recent article from Stanford showcasing Tom Rando’s fantastic leadership and Katie Maguire’s work to develop an exciting new mouse model.

  1. 05.17.2013 Study Sites more
  2. 05.07.2013 AAV5.Dysferlin Gene Therapy as a Treatment for Dysferlinopathies more
  3. 05.07.2013 Measuring Reactive Oxygen Species (ROS) in Mouse Models of Dysferlinopathy more
  4. 05.06.2013 Clinical Studies and Trials for LGMD2B/Miyoshi Myopathy/Dysferlinopathy Patients more